• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FERRITIN; RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FERRITIN; RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN Back to Search Results
Catalog Number 03737551190
Device Problems Low Test Results (2458); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2023
Event Type  malfunction  
Manufacturer Narrative
The alarm trace showed that there was an abnormal magnet movement.Investigation is ongoing.
 
Event Description
We received an allegation of questionable results for 4 patients' samples tested with elecsys ferritin assay on a cobas e411 module serial number (b)(4).The following results were reported: on (b)(6) 2023: sample 1: 0.7 g/l rerun 54.94 g/l.Sample 2: <0.5 g/l rerun 286.2 g/l.On (b)(6) 2023: sample 3: 0.623 g/l rerun 352.3 g/l and 353.5 g/l.Sample 4: 0.868 g/l rerun 67.28 g/l.On (b)(6) 2023 calibration was performed and the signals were slightly lower than the expected range but they seemed okay.Qc recovery showed that it was close to the target.
 
Manufacturer Narrative
The field service engineer (fse) conducted a performance check and the instrument was performing within specifications.The fse also did paddle, magnet, and probe adjustments.Calibration was performed on (b)(6) 2023.The signals were slightly lower than the expected range.Qc was acceptable.A general reagent problem can be excluded.The reagent performs with specifications.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FERRITIN
Type of Device
RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16677043
MDR Text Key312642459
Report Number1823260-2023-01092
Device Sequence Number1
Product Code JMG
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
K971833
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03737551190
Device Lot Number695220
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/08/2023
Initial Date FDA Received04/04/2023
Supplement Dates Manufacturer Received05/02/2023
Supplement Dates FDA Received05/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-